loader
Please Wait
Applying Filters...

Information, Expiry & Status of Health Canada Patents covering Latanoprost.

Menu
$ API Ref.Price (USD/KG) : 1,321,571Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Pfizer Canada Inc.

02 1Robic

03 1Blank

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass
Left Arrow
Right Arrow

01

arrow
Formnext Forum
Not Confirmed
arrow
Formnext Forum
Not Confirmed

Latanoprost

Brand Name : XALATAN

Patent Number : 1339132

Filing Date : 1989-09-12

Strength per Unit : 50mcg / ml

Dosage Form : Liquid

Human Or VET : Human

Route of Administration : Topical (Ophthalmic)

Patent Expiration Date : 2014-07-29

Date Granted : 1997-07-29

blank

02

arrow
Formnext Forum
Not Confirmed

Country
arrow
Formnext Forum
Not Confirmed

Latanoprost

Brand Name :

Patent Number : 1208560

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2003-07-29

Date Granted :

blank

03

Robic

arrow
Formnext Forum
Not Confirmed

Robic

Country
arrow
Formnext Forum
Not Confirmed

Latanoprost

Brand Name : MONOPROST

Patent Number : 2802816

Filing Date : 2011-06-28

Strength per Unit : 0.05 mg / mL

Dosage Form : SOLUTION

Human Or VET : Human

Route of Administration : OPHTHALMIC

Patent Expiration Date : 2031-06-28

Date Granted : 2015-05-12

blank